Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

Source: Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials – ScienceDirect

Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and… – PubMed – NCBI

Source: Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and… – PubMed – NCBI

Clinical features of Mycobacterium canettii infection: a retrospective study of 20 cases among French soldiers and relatives

Source: Clinical features of Mycobacterium canettii infection: a retrospective study of 20 cases among French soldiers and relatives | Clinical Infectious Diseases | Oxford Academic

Effect of early oseltamivir treatment on mortality in critically ill patients with different types of influenza: a multi-season cohort study

Source: Effect of early oseltamivir treatment on mortality in critically ill patients with different types of influenza: a multi-season cohort study | Clinical Infectious Diseases | Oxford Academic

Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial

Source: Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial – Clinical Microbiology and Infection

Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility?

Source: Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility? | Clinical Infectious Diseases | Oxford Academic